𝔖 Bobbio Scriptorium
✦   LIBER   ✦

808 ABVD or EBVD as first line chemotherapy in Hodgkin's disease (HD)

✍ Scribed by M. Dómine; F. Lobo; L. Estévez; E. Garcia Rico; C. Casimiro; M. Lloret; J. Andrade; L. Robles; J. Vicente

Book ID
116167554
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
161 KB
Volume
31
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radiotherapy as salvage treatment in pat
Radiotherapy as salvage treatment in patients with hodgkin's disease or non-hodgkin's lymphoma relapsing after initial chemotherapy
✍ Carine Kirkove; Adrian R. Timothy 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB

## Abstract The prognosis of relapsing Hodgkin's disease (HD) and high grade aggressive non‐Hodgkin's lymphoma (NHL) is generally poor since many of these patients fail to respond to second line chemotherapy. Radiation therapy has been reported as an effective but seldom used, alternative treatment

Etoposide in combination as first-line c
Etoposide in combination as first-line chemotherapy for advanced Hodgkin disease. A cancer and leukemia group B study
✍ Jeffrey J. Kirshner; James R. Anderson; Barbara Parker; Maurice Barcos; M. Rober 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB 👁 1 views

Background. In a pilot study, Cancer and Leukemia Group B (CALGB) incorporated etoposide into primary combination therapy for advanced Hodgkin disease. Thirty-six evaluable patients were treated with two or three courses of methotrexate, vincristine, prednisone, leucovorin, etoposide, and cyclophos